Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. IMA Clinical Research - St. Petersburg

Verified

Basic Information

Site Overview

Source: Human-provided.

IMA Clinical Research is a US-based clinical research network that conducts site-based, hybrid, and decentralized clinical trials across multiple therapeutic areas. The organization partners with sponsors and CROs to support the development of new medical treatments through a nationwide network of clinical research sites and more than 150 satellite locations. Its operations focus on broad patient access, diversity in recruitment, and technology-enabled trial delivery models. The company maintains a patient database of over 400,000 participants and reports access to more than 10,000 unique patient visits weekly. IMA Clinical Research conducts studies in areas including cardiology, neurology, psychiatry, endocrinology, infectious diseases, obesity, vaccines, dermatology, and metabolic disorders. The organization also emphasizes patient outreach, centralized contracting, and regulatory compliance to improve enrollment, retention, and study efficiency.

Source: Trial-derived.
12Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
5Active Trials
Source: Trial-derived.
6Completed Trials
Source: Trial-derived.
15Unique Conditions
Source: Trial-derived.
9Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Obesity (4)Source: Trial-derived. Overweight (3)Source: Trial-derived. Atopic Dermatitis (2)Source: Trial-derived. Cardiovascular Diseases (1)Source: Trial-derived. Chronic Low Back Pain (CLBP) (1)Source: Trial-derived. Diabetes Mellitus, Type 2 (1)Source: Trial-derived. Diabetic Peripheral Neuropathic Pain (1)Source: Trial-derived. Gout (1)

Sponsors

Source: Trial-derived. Eli Lilly and Company (3)Source: Trial-derived. ModernaTX, Inc. (2)Source: Trial-derived. Amgen (1)Source: Trial-derived. Arena Pharmaceuticals (1)Source: Trial-derived. Boehringer Ingelheim (1)Source: Trial-derived. Ionis Pharmaceuticals, Inc. (1)Source: Trial-derived. LG Chem (1)Source: Trial-derived. Reata, a wholly owned subsidiary of Biogen (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Body composition measurement
Source: AI-inferred. Electronic patient-reported outcome diary
Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Hepatic fat fraction quantification
Source: AI-inferred. Subcutaneous study drug administration